DalsnaFinance › IPOs › Vogenx › IPO
Vogenx, Inc. completed its initial public offering on Nasdaq on August 10, 2026, pricing at $13.00 a share.
| Ticker | VOGX |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | August 10, 2026 |
| Offering price | $13.00 |
| Shares offered | 6,250,000 |
| Total raised | $81M |
| Sector | Pharmaceutical Preparations |
Vogenx, Inc. listed on Nasdaq on 2026-08-10.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 1903784.
Vogenx, Inc. sold 6,250,000 shares at $13.00 each on Nasdaq. Multiplied out, that is $81.3 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $81 million total recorded for the deal.
Measured by money raised, Vogenx, Inc. was the 353rd largest of 467 completed IPOs with a recorded deal size that this site tracks since October 23, 2024. The median deal in the same window raised $200 million.
Among the 8 listings on Nasdaq alone, it is the 7th largest.
August 2026 saw 30 completed IPOs in the site's data; by amount raised, Vogenx, Inc. was the 2nd largest of the 2 deals with a recorded size.
Its $13.00 offer price was tied for the 141st highest (level with 2 other listings) of the 483 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Vogenx, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Vogenx, Inc.. This page is general information, not investment advice.